213 results on '"Orit Pinhas-Hamiel"'
Search Results
202. Detection of proviral human T-cell lymphotrophic virus type I DNA in mouthwash samples of HAM/TSP patients and HTLV-I carriers
- Author
-
B. Shohat, L. Doll, Anat Achiron, R. Djaldetti, Orit Pinhas-Hamiel, Yoram Barak, Daniel Offen, and G. Frankel
- Subjects
Male ,viruses ,Population ,Molecular Sequence Data ,Dot blot ,Biology ,Iran ,Polymerase Chain Reaction ,Virus ,Proviruses ,immune system diseases ,Pregnancy ,hemic and lymphatic diseases ,Virology ,Tropical spastic paraparesis ,medicine ,Ethnicity ,Humans ,Israel ,education ,DNA Primers ,education.field_of_study ,Human T-lymphotropic virus 1 ,Mouth ,Base Sequence ,Milk, Human ,Infant, Newborn ,virus diseases ,General Medicine ,Provirus ,medicine.disease ,Infectious Disease Transmission, Vertical ,Paraparesis, Tropical Spastic ,Jews ,Immunology ,Carrier State ,DNA, Viral ,Female ,Viral disease ,Asymptomatic carrier ,Nested polymerase chain reaction - Abstract
Human T-cell lymphotrophic virus type I (HTLV-I), is a member of the oncogenic retroviruses family endemic in several parts of the world and also recently identified in the Jewish Mashhadi population who immigrated from Iran to Israel. The virus is the causative agent of adult T-cell leukemia (ATL) and a chronic myelopathy known both as tropical spastic paraparesis (TSP) or HTLV-I associated myelopathy (HAM). The known modes of HTLV-I transmission are by sexual intercourse, from mother to child in breast milk, via blood transfusion, and by sharing of needles by parenteral drug users. In the present study we examined the presence of HTLV-I provirus genomic DNA by nested polymerase chain reaction (PCR) and by DNA hybridization in mouthwash samples obtained from 13 Mashhadi-born Iranian Jews with spastic paraparesis associated with HTLV-I, 4 Mashhadi-born Iranian Jews asymptomatic carriers for HTLV-I and 21 healthy controls. Proviral HTLV-I DNA was detected by mouthwash PCR in 12 of 17 HTLV-I infected subjects (71%) but in none of 21 controls. Proviral DNA was also detected in mouthwash samples using HTLV-I probe by dot blot hybridization assay. The presence of HTLV-I proviral DNA in whole saliva may suggest a possible transmission of the virus via saliva and explain the increased rate of infection in elderly Mashhadi-Jewish population.
- Published
- 1996
203. Children with Oligoarticular Juvenile Idiopathic Arthritis are at Considerable Risk for Growth Retardation
- Author
-
Orit Pinhas-Hamiel, Dorith Zimmermann-Sloutskis, Yackov Berkun, and Shai Padeh
- Subjects
Male ,musculoskeletal diseases ,medicine.medical_specialty ,Adolescent ,medicine.drug_class ,Group ii ,Blood Sedimentation ,Disease ,Triamcinolone Acetonide ,Injections, Intra-Articular ,Internal medicine ,medicine ,Humans ,Age of Onset ,Child ,skin and connective tissue diseases ,Glucocorticoids ,Growth Disorders ,Retrospective Studies ,Growth retardation ,medicine.diagnostic_test ,business.industry ,Infant ,Elevated erythrocyte sedimentation rate ,Arthritis, Juvenile ,Body Height ,Endocrinology ,Antirheumatic Agents ,Child, Preschool ,Erythrocyte sedimentation rate ,Pediatrics, Perinatology and Child Health ,Corticosteroid ,Female ,Oligoarticular Juvenile Idiopathic Arthritis ,business ,Linear growth ,Follow-Up Studies - Abstract
To assess linear growth in patients with persistent oligoarticular juvenile idiopathic arthritis (JIA) treated by intra-articular corticosteroid injections (IACSI).Data were obtained from a retrospective review of the charts of 95 patients with persistent oligoarticular JIA (69 females). The mean age at first visit was 4.9 ± 3.4 years, with follow-up of 6 ± 3.7 years. The height SDS for chronologic age (z-score) was correlated with the clinical course of the disease and compared among patients treated by IACSI alone (group I) or by a combination of disease-modifying antirheumatic drugs (DMARDs) (group II).Growth retardation was found in 35.8% of patients (Δ z-score-0.3), including 11.6% with severe growth retardation (Δ z-score-1.0). Growth retardation was found in a smaller proportion of patients in group I (any growth retardation, 30.6%; severe growth retardation, 6.5%) than in patients in group II (any growth retardation, 44.4%; severe growth retardation, 21.2%; P.05). Elevated erythrocyte sedimentation rate values (≥ 40 mm/1sth) indicated a significantly higher risk for growth retardation. All other clinical variables had no association with growth retardation.A significant proportion of patients with persistent oligoarticular JIA have growth retardation and a minority have severe growth retardation. Only elevated erythrocyte sedimentation rate values were proven to be a good predictor of risk for growth retardation.
- Published
- 2011
204. Type 2 Diabetes in Adolescents, No Longer Rare
- Author
-
Orit Pinhas-Hamiel and Philip Zeitler
- Subjects
Family Health ,Pediatrics ,medicine.medical_specialty ,Adolescent ,business.industry ,Incidence ,Type 2 diabetes ,medicine.disease ,Diabetes Mellitus, Type 1 ,Text mining ,Diabetes Mellitus, Type 2 ,Pediatrics, Perinatology and Child Health ,medicine ,Humans ,business ,Life Style - Published
- 1998
205. The Type 2 Family
- Author
-
Debra Standiford, Lawrence M. Dolan, Robert M. Cohen, Daniel Hamiel, Philip Zeitler, and Orit Pinhas-Hamiel
- Subjects
Adult ,Male ,Pediatrics ,medicine.medical_specialty ,Adolescent ,Type 2 diabetes ,Feeding and Eating Disorders ,chemistry.chemical_compound ,Insulin resistance ,Risk Factors ,Diabetes mellitus ,medicine ,Humans ,Obesity ,Age of Onset ,Child ,Exercise ,Life Style ,Ohio ,Family Health ,Analysis of Variance ,Anthropometry ,C-peptide ,business.industry ,Type 2 Diabetes Mellitus ,Feeding Behavior ,Middle Aged ,medicine.disease ,Eating disorders ,Diabetes Mellitus, Type 2 ,chemistry ,Pediatrics, Perinatology and Child Health ,Female ,business ,Body mass index - Abstract
Objective To identify physical, behavioral, and environmental features of adolescents (aged 11-17 years) with type 2 diabetes mellitus and their families to define the involvement of known risk factors and to define a profile of at-risk individuals. Design and Methods A total of 42 subjects from 11 families with an adolescent in whom type 2 diabetes was previously diagnosed participated. All subjects underwent anthropometric measurement and completed food frequency and eating disorder questionnaires, and were classified according to theDiagnostic and Statistical Manual of Mental Disorders, Fourth Edition. In addition, laboratory tests to determine levels of hemoglobin A1c, fasting glucose, C peptide, insulin, and proinsulin were performed. Results Type 2 diabetes had been diagnosed in 5 of 11 mothers and 4 of 11 fathers before the study. Type 2 diabetes was diagnosed in 3 of the remaining 7 fathers during the study. In 3 families, both parents were affected with type 2 diabetes. As a group, participants were obese, with a body mass index higher than the 95th percentile for probands and fathers, and higher than the 85th percentile for mothers and siblings. The sum of skin fold measurements was above the 95th percentile for the probands, their siblings, and the parents. All groups had high fat intake and low fiber intake. None of the subjects participated in a structured or routine exercise program, and most reported no regular physical activity. Three of the probands met the criteria for binge-eating disorder, and 6 additional patients had notable characteristics of the disorder. Mothers affected with type 2 diabetes had markedly abnormal hemoglobin A1clevels, indicating poor control. There were no group differences in fasting concentrations of insulin, proinsulin, or C peptide. However, a third of the mothers with type 2 diabetes, and all but 1 of the siblings, had evidence of insulin resistance. Conclusions Adolescents in whom type 2 diabetes has been diagnosed, as well as their first-degree family members, are obese. In addition, the incidence of diagnosed and undiagnosed type 2 diabetes or of insulin resistance in the families of adolescents with type 2 diabetes is striking. Probands and other family members have lifestyles characterized by high fat intake, minimal physical activity, and a high incidence of binge eating. These findings indicate that the families of adolescents with type 2 diabetes share many anthropometric and lifestyle risk factors. The design of treatment programs for adolescents with type 2 diabetes will need to address the lifestyle and health habits of the entire family.
- Published
- 1999
206. Juvenile Multiple Sclerosis - Clinical and Prognostic Characteristics 1894
- Author
-
Izhak Ziev-Ner, Yoram Barak, Orit Pinhas-Hamiel, and Anat Achiron
- Subjects
Pathology ,medicine.medical_specialty ,business.industry ,Multiple sclerosis ,Internal medicine ,Pediatrics, Perinatology and Child Health ,medicine ,Juvenile ,medicine.disease ,business - Published
- 1998
207. Risk Factors for Diabetes among Family Members of Adolescents with Type 2 Diabetes † 15
- Author
-
Orit Pinhas-Hamiel, Mary-Pat Alfaro, Lawrence M Dolan, Deborah Staniford, and Philip Zeitler
- Subjects
Pediatrics ,medicine.medical_specialty ,Diabetes risk ,Binge eating ,business.industry ,Incidence (epidemiology) ,Insulin ,medicine.medical_treatment ,Type 2 diabetes ,medicine.disease ,Insulin resistance ,Binge-eating disorder ,Diabetes mellitus ,Pediatrics, Perinatology and Child Health ,Medicine ,medicine.symptom ,business - Abstract
We hypothesized that type 2 diabetes among adolescents occurs within families in which known diabetes risk factors are prevalent. Therefore,we investigated these families in order to define the presence of known risk factors and to determine whether a profile of the at-risk family can be identified. A total of 42 subjects from 11 families with adolescent previously diagnosed with type 2 diabetes participated. All subjects underwent anthropometric measurements, as well as determination of fasting glucose, HbA1c C-peptide, pro-insulin, and insulin. Subjects also completed food frequency and DSMIV eating disorder questionnaires. Results: Forty-five percent of mothers and 36% of fathers had been diagnosed with type 2 diabetes prior to the study. An additional 40% of the fathers were diagnosed with type 2 diabetes as part of their participation. Mothers affected with type 2 diabetes had markedly abnormal hemoglobin A1c values indicating poor control. As a group, participants were obese, with BMI above the 95%ile for probands and fathers, and at the 85%ile for mothers and siblings. The sum of skin folds was above the 95% percentile for the patients, their siblings and the parents. All groups had high fat intake and low fiber intake. None of the subjects participated in a structured or routine exercise program and the vast majority reported no regular physical activity. Three (27%) of the probands met the criteria for Binge Eating Disorder and six additional patients had significant characteristics of the disorder. None of the siblings (mean age 14±0.3 yrs) had elevated glucose or HbA1c levels. However, siblings had markedly elevated fasting C-peptide (0.69 ± 0.13 nmol/L vs normal 0.46± 0.03) and proinsulin levels (20.1 ± 5.1 pmol/L vs normal 8.6± 0.64). Previously undiagnosed mothers also displayed signs of insulin resistance, with C-peptide of 0.85 ± 0.12 nmnol/l and proinsulin of 18.8 ± 8.6 pmol/l. CONCLUSIONS: Probands, as well as other family members, are centrally obese and have lifestyles characterized by high fat intake, minimal physical activity and a high incidence of binge eating disorders. Furthermore, the incidence of diagnosed and undiagnosed type 2 diabetes and insulin resistance in these families is striking. Taken together, these findings suggest that adolescent type 2 diabetes frequently occurs in a high-risk family setting and indicate that screening of family members for diabetes may be appropriate. Furthermore, treatment programs for adolescents with type 2 diabetes will need to address the lifestyle and health habits of the entire family.
- Published
- 1998
208. Long-Term Insulin Pump Treatment in Girls with Type 1 Diabetes and Eating Disorders—Is It Feasible?
- Author
-
Orit Pinhas-Hamiel, Chana Graph-Barel, Valentina Boyko, Michal Tzadok, Liat Lerner-Geva, and Brian Reichman
- Subjects
- *
INSULIN pumps , *TREATMENT of diabetes , *TREATMENT of eating disorders , *DIABETES in adolescence , *HEMOGLOBINS , *FEASIBILITY studies - Abstract
AbstractAim:This study evaluated the feasibility of insulin pump treatment in adolescent girls with type 1 diabetes mellitus (T1DM) and eating disorders (ED).Methods:Sixty-three girls >10 years old were included in the study. Forty-eight were treated with pump (no-ED-pump group); 15 had ED, of whom eight were treated with pump (ED-pump group), and seven were treated with multiple daily injections (MDI) (ED-MDI group).Results:Girls in the ED-pump group had higher hemoglobin A1c (HbA1c) compared to those in the no-ED-pump group both before and after pump initiation (P= 0.007). In the ED-pump group, levels 0–6 months after pump initiation were slightly but not significantly lower compared to baseline reference values (8.48% vs. 8.84%, respectively; P= 0.42). In the no-ED-pump group there was a significant decrease in HbA1c level 0–6 months after pump initiation (8.03% vs. 7.67%, respectively; P= 0.004). Thereafter HbA1c levels were not different from baseline reference on both groups. The rate of hypoglycemic episodes was similar in the ED pump and no-ED-pump groups (0.9 vs. 1.0 episodes per 100 patient-years, respectively). Prior to diagnosis of ED, mean HbA1c levels in the ED-pump group and the ED-MDI group were similar: 9.24 ± 1.25% versus 8.47 ± 1.30% (P= 0.51). In the time intervals after the diagnosis of ED, mean HbA1c level of all measurements in the eight girls in the ED-pump group was significantly lower compared with the seven patients in the ED-MDI group: 9.07 ± 1.33% versus 10.40 ± 2.01% (P= 0.04).Conclusions:Treatment with an insulin pump was feasible in girls with T1DM and ED and resulted in significantly lower HbA1c levels compared to the ED-MDI group. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
209. A life-threatening sexually transmitted Haemophilus influenzae in septic abortion: A case report
- Author
-
Eyal Schiff, Orit Pinhas-Hamiel, Shlomo Mashiach, Brian Reichman, and Gilad Ben-Baruch
- Subjects
Adult ,Pediatrics ,medicine.medical_specialty ,Haemophilus Infections ,Sexual transmission ,Sexually Transmitted Diseases ,Abortion, Septic ,Abortion ,medicine.disease_cause ,Haemophilus influenzae ,Pregnancy ,medicine ,Humans ,Septic abortion ,biology ,Genitourinary system ,business.industry ,Pasteurellaceae ,virus diseases ,Obstetrics and Gynecology ,Shock ,Disseminated Intravascular Coagulation ,bacterial infections and mycoses ,biology.organism_classification ,medicine.disease ,Bacteremia ,Immunology ,Female ,Hypotension ,business - Abstract
Haemophilus influenzae infections of the genitourinary tract are rare. A case of a life-threatening Haemophilus influenzae bacteremia associated with a septic abortion is presented. Sexual transmission of bacteria after orogenital contact is proposed as a possible source of this uncommon infection.
- Published
- 1991
210. Serial in utero ultrasonographic measurements of the fetal thyroid: a new complementary tool in the management of maternal hyperthyroidism in pregnancy.
- Author
-
Ohad Cohen, Orit Pinhas-Hamiel, Eyal Sivan, Mordechai Dolitski, Shlomo Lipitz, and Reuwen Achiron
- Abstract
Treatment of maternal hyperthyroidism during pregnancy is complicated by the lack of readily available measures of the thyroid status of the fetus. The aim of this study is to describe the use of serial in utero ultrasound measurements of fetal thyroid in patients being treated for Graves' disease in pregnancy. Over a 24-month period, all pregnant women with Graves' disease attending our special Fetal Thyroid Unit were followed. Maternal thyroid status was assessed by thyroid function tests. Fetal thyroid size was measured serially by transvaginal ultrasonography between 14 and 17 weeks of gestation and by abdominal ultrasonography between 18 and 37 weeks of gestation in 20 women with Grave's disease. In 15 fetuses, thyroid width and circumference were within the 95% confidence interval of the normal population. In five fetuses, thyroid size was above the 95th percentile for gestational age. In three of them, thyroid size decreased concurrently with a decrease in maternal thionamide dosage, reaching normal range. These three fetuses were born euthyroid. In two fetuses, thyroid size was unaffected by a decrement in maternal drug dosage. Both had neonatal thyrotoxicosis at birth. Serial in utero ultrasonography measuring fetal thyroid size in mothers with Graves' disease can serve as an effective noninvasive tool for the early detection of enlarged fetal thyroid. These findings can be used to monitor the maternal antithyroid drug dosage, thereby preventing intrauterine hypothyroidism in some cases. When a dosage reduction does not cause a decrease in fetal thyroid size, transplacental passage of thyroid-stimulating antibodies causing fetal thyrotoxicosis should be suspected. Copyright © 2003 John Wiley & Sons, Ltd. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
211. Acute neuroleptic induced leukopenia in Ethiopian jews with benign familial leukopenia
- Author
-
Daniel Levy, Yoram Barak, Alex Aviv, Avner Elizur, Orit Pinhas-Hamiel, and R. Kimhi
- Subjects
medicine.medical_specialty ,Leukopenia ,business.industry ,Health Policy ,Public Health, Environmental and Occupational Health ,General Medicine ,Neutropenia ,medicine.disease ,Gastroenterology ,Acute illness ,Internal medicine ,medicine ,medicine.symptom ,business - Abstract
Benign familial leukopenia (BFL) has been described in various ethnic groups around the world; in Israel it is found among Yemenites and Ethiopians. Neuroleptics infrequently cause acute leukopenia. We described nine Ethiopian subjects who were treated with conventional antipsychotics for four weeks. In three subjects probable BFL was demonstrated prior to treatment. By the end of four weeks of treatment 6/9 subjects developed leukopenia with neutropenia. Reduction in mean WBC counts and neutrophil counts was significant (p=0.014 and p=0.001, respectively).None of the subjects developed an acute illness or an infection during the studied period. We tentatively suggest that in subjects belonging to ethnic groups where BFL is common antipsychotics may induce its expression without significant clinical symptomatology.
212. A Novel Mutation in the Thyroglobulin Gene Resulting in Neonatal Goiter and Congenital Hypothyroidism in an Eritrean Infant
- Author
-
Eve Stern, Nadia Schoenmakers, Adeline K. Nicholas, Eran Kassif, Orit Pinhas Hamiel, and Yonatan Yeshayahu
- Subjects
congenital goiter ,hypothyroidism ,thyroglobulin ,novel mutation ,case report ,Pediatrics ,RJ1-570 ,Diseases of the endocrine glands. Clinical endocrinology ,RC648-665 - Abstract
Congenital hypothyroidism (CH) due to dyshormonogenesis may occur due to mutations in any of the key genes involved in thyroid hormone biosynthesis (TG, TPO, DUOX2, DUOXA2, SLC5A5, IYD, SLC26A4 and SLC26A7). Mutations in the thyroglobulin gene (TG) are frequently associated with goiter, which may present fetally or neonatally, although a spectrum of phenotypes is reported. We present the case of a woman of Eritrean origin who presented in the third trimester of pregnancy in the early stages of labor. Ultrasound at presentation revealed a fetal neck swelling consistent with a goiter. Following delivery by Caesarian section with minimal respiratory support, the infant was found to be hypothyroid with undetectable serum levels of thyroglobulin. Sequencing of the TG revealed a homozygous donor splice site pathogenic variant (c.5686+1delG) not previously described in the literature. Levothyroxine treatment resulted in normal growth and psychomotor development. Goitrous CH with inappropriately low thyroglobulin has previously been reported in patients harbouring homozygous single nucleotide substitutions at the same TG donor splice site, which result in exon skipping and retention of malformed thyroglobulin by the endoplasmic reticulum. We conclude that the TG c.5686+1delG pathogenic variant is the likely basis for our patient’s fetal goiter and CH, and that the clinical phenotype associated with TG c.5686+1delG is comparable to that seen with single nucleotide substitutions at the same site.
- Published
- 2022
- Full Text
- View/download PDF
213. Eating disorders in adolescents with type 1 diabetes: Challenges in diagnosis and treatment.
- Author
-
Pinhas-Hamiel O, Hamiel U, and Levy-Shraga Y
- Abstract
Eating disorders (ED) are characterized by a persistent disturbance of eating that impairs health or psychosocial functioning. They are associated with increased rates of medical complications and mortality. Insulin omission is a unique purging behavior available to individuals with type 1 diabetes mellitus (T1DM). The standard treatment regimen for T1DM requires a major focus on food and eating patterns. Moreover, intensive insulin therapy is associated with increasing body weight. These factors, combined with the psychological burden of chronic disease management and depression, may contribute to ED. The comorbidity of ED in T1DM patients is associated with poorer glycemic control and consequently higher rates of diabetes complications. Early recognition and adequate treatment of ED in T1DM is essential.
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.